Drug class
Intravenous angiotensin-converting enzyme (ACE) inhibitor; active metabolite of enalapril
Mechanism of action
Inhibits ACE, reducing conversion of angiotensin I to angiotensin II and decreasing aldosterone secretion. This reduces vasoconstriction and sodium retention and lowers blood pressure.
General use cases
- Treatment of hypertension when oral therapy is not practical or appropriate using the intravenous formulation; dosing and monitoring are product- and setting-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
